Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Strategies and Pharmaceutical Agents for the Treatment of Leish-Maniasis: A Review Publisher



Nilforoushzadeh MA1 ; Heidarikharaji M1 ; Zare M1 ; Torkamaniha E1 ; Rafati S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immuno-therapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran

Source: Anti-Infective Agents Published:2020


Abstract

Leishmaniasis is a major tropical disease. There is no effective vaccine against leish-maniasis and chemotherapy is still the most effective treatment for the disease. However, most of the common drugs have many disadvantages such as toxicity and high cost. Most important of all is the development of resistance against these drugs. Many studies have tried to provide new pharmaceutical agents and formulations in various ways to overcome these problems. In recent years, medical plants have been widely considered for leishmaniasis treatment. Besides, various drug delivery strategies have been studied for the treatment of leishmaniasis in order to increase activity and reduce the side effects of the drugs. Accordingly, nanotechnology will play an important role in the preparation of new pharmaceutical formulations. In this review, we focused on various therapeutic approaches for leishmaniasis. © 2020, Bentham Science Publishers. All rights reserved.
Other Related Docs
11. Development of a Topical Liposomal Formulation of Amphotericin B for the Treatment of Cutaneous Leishmaniasis, International Journal for Parasitology: Drugs and Drug Resistance (2019)
12. In Vitro and In Vivo Susceptibility of Leishmania Major to Some Medicinal Plants, Asian Pacific Journal of Tropical Biomedicine (2017)
14. Development of Nano-Carriers for Leishmania Vaccine Delivery, Expert Opinion on Drug Delivery (2020)